Effects of Limosilactobacillus reuteri DSM 17938 in neonates exposed to antibiotics: a randomised controlled trial

What is it about?

Perinatal antibiotic exposure potentially leads to infants’ gut dysbiosis. We aimed to investigate the potential benefits of probiotic intervention during early life following neonatal antibiotic exposure. Our findings revealed a significant decrease in the incidence of FGID in the probiotic group compared to the control group six months after enrollment. Given the widespread use and importance of antibiotic treatment in neonates these findings have significant implications for pediatric healthcare, offering a novel approach to managing the risks associated with perinatal antibiotic use.

Featured Image